Potentiation of quinazoline antifolate (CB3717) toxicity by dipyridamole in human lung carcinoma, A549, cells

This publication has 40 references indexed in Scilit:

• Modulation of anti-metabolite effects
  Biochemical Pharmacology, 1984
• Salvage capacity of hepatoma 3924A and action of dipyridamole
  Advances in Enzyme Regulation, 1983
• Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid (CB3717), on human lymphoblastoid cells
  Biochemical Pharmacology, 1983
• Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexate
  Cancer Chemotherapy and Pharmacology, 1981
• A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice
  Published by Elsevier ,1981
• Quantitative high-performance liquid chromatography of nucleosides and bases in human plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1980
• Thymidine concentrations in serum and urine of different animal species and man
  Biochemical Pharmacology, 1977
• A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells
  International Journal of Cancer, 1976
• The deoxyribonucleoside transport systems of cultured Novikoff rat hepatoma cells
  Journal of Cellular Physiology, 1974
• In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2
  JNCI Journal of the National Cancer Institute, 1973